This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to learn whether obstructive sleep apnea (OSA), a condition in which breathing is affected during sleep, can cause abnormal blood sugar (glucose) processing, which could lead to diabetes, or pre-diabetic conditions. In addition, both OSA and diabetes are linked to autonomic dysfunction of the parasympathetic and sympathetic nervous system, which controls heart rate and blood pressure. It is unclear whether the autonomic dysfunction found in OSA is due to diabetic or pre-diabetic conditions, or whether it caused by OSA independently. OSA and diabetes are commonly found in overweight individuals and both can cause increased risk of heart disease and strokes. Autonomic dysfunction is thought to increase the risk of heart disease in both of these conditions. OSA is a treatable condition, utilizing nasal continuous positive airway pressure (CPAP), which blows air into the nose, overcoming the obstruction to airflow that occurs in OSA. During this study, subjects identified by their doctors as having symptoms of OSA and referred for a sleep study (polysomnogram or PSG) will be asked to participate in this study. Patients will undergo a PSG to determine whether they have OSA. The following morning, patients will be asked to undergo a glucose tolerance test (OGTT) in which blood is taken before and after drinking a sugary drink. Several tests of the autonomic system will be performed. Patients who are diagnosed with OSA will be brought back to the sleep lab to determine what kind of CPAP is needed for their treatment and given a prescription. After 6 months, patients will be asked to return for a second OGTT and repeat autonomic tests. By performing this study, we hope to learn whether patients with OSA have an increased prevalence of diabetes or pre-diabetic condition, characterize the autonomic dysfunction associated with these disorders, and determine whether nasal CPAP will improve glucose metabolism and/or autonomic function in people who do have abnormal processing of blood sugar.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR000042-46
Application #
7376573
Study Section
Special Emphasis Panel (ZRR1-CR-8 (02))
Project Start
2006-04-05
Project End
2007-02-28
Budget Start
2006-04-05
Budget End
2007-02-28
Support Year
46
Fiscal Year
2006
Total Cost
$10,730
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Spengler, Erin K; Kleiner, David E; Fontana, Robert J (2017) Vemurafenib-induced granulomatous hepatitis. Hepatology 65:745-748
Heidemann, Lauren; Law, James; Fontana, Robert J (2017) A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury. Dig Dis Sci 62:615-625
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419
Law, Ian H; Alam, Osman; Bove, Edward L et al. (2016) Follow-Up of a Prospective Surgical Strategy to Prevent Intra-Atrial Reentrant Tachycardia After the Fontan Operation. Circ Arrhythm Electrophysiol 9:
Schrepf, Andrew; Harper, Daniel E; Harte, Steven E et al. (2016) Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157:2217-2225
As-Sanie, Sawsan; Kim, Jieun; Schmidt-Wilcke, Tobias et al. (2016) Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain. J Pain 17:1-13

Showing the most recent 10 out of 1380 publications